Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CTSS | P25774 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5398002 | 1.00 | CA1 (0.39) | CA1CA2CA7CTSKALDH1A1 | |
| SCHEMBL5397999 | 1.00 | CA1 (0.39) | CA1CA2CA7CTSKALDH1A1 | |
| SCHEMBL14427080 | 0.86 | CA1 (0.40) | CA1CA2CA7CTSKALDH1A1 | |
| SCHEMBL13134796 | 0.84 | CTSS (0.42) | CTSKCTSS | |
| SCHEMBL8292289 | 0.81 | CA1 (0.36) | CA1CA2CA7CTSKALDH1A1 | |
| SCHEMBL8249385 | 0.80 | LMNA (0.50) | CA1CA2CA7CTSKALDH1A1 | |
| SCHEMBL3622690 | 0.80 | LMNA (0.44) | TSHRLMNA | |
| SCHEMBL5521975 | 0.80 | LMNA (0.44) | TSHRLMNA | |
| SCHEMBL3622689 | 0.80 | LMNA (0.44) | TSHRLMNA | |
| SCHEMBL5394636 | 0.78 | CA1 (0.39) | CA1CA2CA7CTSKALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1446392-A1 | OLIGOPEPTIDES AND COMPOSITIONS CONTAINING THEM AS CATHEPSIN S INHIBITORS | Aventis Pharmaceuticals, Inc. (US) | 2004-08-18 | — | — | EP | disclosed |
| WO-2003042197-A1 | OLIGOPEPTIDES AND COMPOSITIONS CONTAINING THEM AS CATHEPSIN S INHIBITORS | AVENTIS PHARMACEUTICALS INC. (US) | 2003-05-22 | — | — | WO | disclosed |